Effect of magnesium and zinc supplementation in the patients of essential hypertension

Authors

DOI:

https://doi.org/10.18203/2320-6012.ijrms20243361

Keywords:

Systolic blood pressure, Diastolic blood pressure, Cardiac output, Essential hypertension, Primary hypertension

Abstract

Background: Primary hypertension is the most common (almost 95%) and it can easily be controlled through lifestyle modification by regular exercise and controlled diet plan. Magnesium and zinc supplementation can alleviate essential hypertension.

Methods: 73 hypertensive patients were recruited. Thrice in a row with interval of 5 minutes, twice a day for 7 days high BP monitoring was done and ensured daily intake of Mg (300 mg) and Zn (10 mg) for 4 weeks. Thereafter again 4th week home Blood pressure monitoring was done. Study was done from 25 April 2023 to 24 April 2024. Secondary hypertension was excluded after proper radiological and pathological investigations.

Results: Decrease in SBP by 6.9 mmHg, pre SBP 141±11.3 SD and post SBP 134±9.6 SD and DBP by 4.8 mmHg, pre DBP 91±7.8SD and Post DBP 86±73, observed after 4 weeks supplementation. In 30 medicated patients, antihypertensive showed decrease in SBP by 4.6 mmHg, pre SBP 137±11.5 SD and post SBP 132±9.6 SD with and DBP by 4.7 mmHg, Pre DBP 89.6±9.2SD and post DBP 84.9±8.7.

Whereas, in a group of 43, without any medicine exhibited decline in SBP by 8 mmHg (Pre SBP 144±10 SD and Post SBP 136±9.5 and DBP by 5 mmHg, pre DBP 92±6.8 SD and post DBP 87±0.6.3 SD. Value of p<0.001 in the study group.

Conclusions: Supplementation reduced blood pressure in all pre and post groups. The effect of supplementation had slighter edge on who were not taking antihypertensive medicine than were taking single medication or combined therapy.

References

Kaess BM, Rong J, Larson MG, Hamburg NM, Vita JA, Levy D, et al. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA. 2012;308:875–81.

Dumor K, Shoemaker-Moyle M, Nistala R, Whaley-Connell A. Arterial stiffness in hypertension: an update. Curr Hypertens Rep. 2018;20:72.

Chirinos JA, Segers P, Hughes T, Townsend R. Large-artery stiffness in health and disease: jacc state-of-the-art review. J Am Coll Cardiol. 2019;74:1237–63.

Wilson J, Webb AJS. Systolic blood pressure and longitudinal progression of arterial stiffness: a quantitative meta-analysis. J Am Heart Assoc. 2020;9:17804-9.

Roush GC, Sica DA. Diuretics for hypertension: a review and update. Am J Hypert. 2016;29:1130–7.

Morris RC, Schmidlin O, Sebastian A, Tanaka M, Kurtz TW. Vasodysfunction that involves renal vasodysfunction, not abnormally increased renal retention of sodium, accounts for the initiation of salt-induced hypertension. Circulation. 2016;133:881-93.

Riet L, van Esch JHM, Roks AJM, van den Meiracker AH, Danser AHJ. Hypertension. Circ Res. 2015;116:960–75.

Parati G, Esler M. The human sympathetic nervous system: its relevance in hypertension and heart failure. Eur Heart J. 2012;33:1058–66.

Mancia G, Grassi G. The autonomic nervous system and hypertension. Circ Res. 2014;114:1804–14

Cabrera CP, Ng FL, Nicholls HL, Gupta A, Barnes MR, Munroe PB, et al. Over 1000 genetic loci influencing blood pressure with multiple systems and tissues implicated. Hum Mol Genet. 2019;28:151–61.

Evangelou E, Warren HR, Mosen-Ansorena D, Mifsud B, Pazoki R, Gao H, et al. Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. Nat Genet. 2018;50:1412–25.

Bruno S, Margiotta M, Marchesani F, Paredi G, Orlandi V, Faggiano S, et al. Magnesium and calcium ions differentially affect human serine racemase activity and modulate its quaternary equilibrium toward a tetrameric form. Biochim. Biophys. Acta. 2017;1865:381-7.

Sinha P, Paswan RK, Kumari A, Kumar S, Bimal S, Das P, Lal CS. Magnesium-Dependent Ecto-ATP Diphosphohydrolase Activity in Leishmania donovani. Curr Microbiol. 2016;73:811-9.

Ge J, Huang F, Nesmelov YE. Metal cation controls phosphate release in the myosin ATPase. Protein Sci. 2017;26:2181-6.

Odom MJ, Zuckerman SL, Mocco J. The role of magnesium in the management of cerebral vasospasm. Neurol Res Int. 2013;2:943914.

Turlapaty PD, Altura BM. Magnesium deficiency produces spasms of coronary arteries: Relationship to Etiology of sudden death ischemic heart disease. Science. 1980;208:198–200.

Agarwal R, Iezhitsa L, Agarwal P. Pathogenetic role of magnesium deficiency in ophthalmic diseases. Biometals. 2014;27:5-18.

Satake K, Lee JD, Shimizu H, Uzui H, Mitsuke YY, Ueda T. Effects of magnesium on prostacyclin synthesis and intracellular free calcium concentration in vascular cells. Magnes Res. 2004;17:20-7.

Shimosawa T, Takano K, Ando K, Fujita T. Magnesium inhibits norepinephrine release by blocking N-type calcium channels at peripheral sympathetic nerve endings. Hypertension. 2004;44:897-902.

Mousavi SM, Mofrad MD, Nascimento IJB, Milajerdi A, Mokhtari T, Esmaillzadeh A. The effect of zinc supplementation on blood pressure: a systematic review and dose-response meta-analysis of randomized-controlled trials. European J Nut. 2020;59(5):1815-27.

Meditation and a relaxation technique to lower blood pressure. 2024. Available at: www.health.harvard.edu/heart-health.

Motoyama T, Sano H, Fukuzaki H. Oral magnesium supplementation in patients with essential hypertension. Hypertension. 1989;13(3):227-32.

Ferrara LA, Iannuzzi R, Castaldo A, Iannuzzi A, Dello Russo A, Mancini M. Long-term magnesium supplementation in essential hypertension. Cardiol. 1992;81(1):25–33.

Downloads

Published

2024-10-30

How to Cite

Singh, S. K., Verma, N., Singh, S., Patel, M. L., & Mittal, A. (2024). Effect of magnesium and zinc supplementation in the patients of essential hypertension. International Journal of Research in Medical Sciences, 12(11), 4136–4141. https://doi.org/10.18203/2320-6012.ijrms20243361

Issue

Section

Original Research Articles